James Wakefield
11Patents
7h-index
21Co-inventors
66Inventor score
Filing activity: Mar 14, 1995 → Sep 14, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5854204A | A.beta. peptides that modulate .beta.-amyloid aggregation | Human Necessities | 118 | Expired |
| US6303567A | Modulators of .beta.-amyloid peptide aggregation comprising D-amino acids | Human Necessities | 89 | Expired |
| US5817626A | Modulators of beta-amyloid peptide aggregation | Human Necessities | 87 | Expired |
| US5854215A | Modulators of .beta.-amyloid peptide aggregation | Human Necessities | 70 | Expired |
| US5985242A | Modulators of .beta.-amyloid peptide aggregation comprising D-amino acids | Human Necessities | 64 | Expired |
| US6319498A | Modulators of amyloid aggregation | Human Necessities | 36 | Expired |
| US6277826A | Modulators of .beta.-amyloid peptide aggregation comprising D-amino acids | Physics | 13 | Expired |
| US6689752B2 | Modulators of &bgr;-amyloid peptide aggregation comprising D-amino acids | Physics | 6 | Expired |
| US7658917B2 | Modulators of amyloid aggregation | Human Necessities | 4 | Expired |
| US7175828B2 | Modulators of β-amyloid peptide aggregation comprising D-amino acids | Physics | 3 | Expired |
| US11389449B2 | Treatment of metabolic syndrome with an sGC stimulator | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.